Probability of overall survival of p190⁺patients versus p210⁺ patients.

Probability of overall survival at 3 years of 135 p190⁺, indicated by the top solid line, (patients (0.19 ± 0.04 SE) and 34 p210⁺ patients, indicated by the bottom broken line, (0.03 ± 0.03 SE) treated in the GMALL studies 04/89 and 05/93. Log-rank P = .07. Median follow-up of 328 days for m-BCR or p190 versus 340 days for M-bcr or p210.